Penn State CTSI

  • slide-webpage

    New KL2 Scholars Named

    Six Penn State researchers have been selected to receive support through the Penn State Clinical and Translational Science Institute’s KL2 Scholar Program.

    More »
  • Gears and Hands

    P3 Initiative: Stage 1 proposals due 4/28

    Penn State Pathway to Partnership provides seed funding & support to stimulate new collaborations & broaden existing collaborations to develop new research directions.

    More »
  • 101163383

    Community Engagement Enhancement Funding

    Funds available for investigators to enhance an existing health-related research project with community engagement. Rolling applications; next round due April 30.

    More »
  • dna2

    Recent Topics in Research Methods

    Join the CTSI for a bi-weekly research methods seminar series throughout the Spring 2015 semester. All seminars will be videoconferenced between University Park and Hershey.

    More »
  • eagle

    eagle-i

    eagle-i, a nationally prominent resource catalog and search tool, is now available at Penn State! By improving the flow of relevant information through the biomedical research community, eagle-i has the potential to accelerate development of diagnostics, treatments, and prevention strategies.

    More »

Penn State CTSI

The most important challenge facing academic medical centers is translating new research findings into tangible health benefits that improve lives. Penn State has created the Clinical and Translational Science Institute (CTSI) to serve as an independent but highly integrated academic engine for clinical and translational science.

The CTSI builds on the strong tradition and rich experience of collaborative interdisciplinary thinking that exists at Penn State and brings this wide breadth of academic endeavor—including traditional biomedical activities, social sciences, arts, communications, economics, education, engineering, ethics, and health care delivery and policy—to bear on health.

The long-range goal of the CTSI is to develop, implement and make available to the community at large new methods to predict, prevent and effectively treat human disease.

Upcoming Events

Addiction Journal Club

April 20 @ 12:00 pm - 1:00 pm
Sponsored by the Penn State Addiction Center for Translation (PS ACT)

The following paper will be discussed:
Johnson, Garcia-Romeu, Cosimano, and Griffiths (2014). Pilot study of a 5-HT2AR agonist psilocybin in the treatment of tobacco addiction. Journal of Psychopharmacology, 28(11), 983-992.
The discussion will be led by Mr. Matt Yuill, Neuroscience Graduate Student at the College of Medicine, affiliated with the Levenson (Pharmacology) and Morgan (Anesthesiology) Laboratories.
RSVP to Sarah Ballard (smb42@psu.edu; x4214) to account for space.
More »
See Full Calendar »

Recent CTSI News